SCHEMBL4781894

SCHEMBL4781894

Cc1ccccc1-c1ccc2c(C(=O)N3CCN(CC(=O)c4ccc(F)cc4)CC3)n[nH]c2c1

nearest known ligand 0.59

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 14/20 0.59
HTR2C P28335 9/20 0.57
ABL1 P00519 5/20 0.50
BCR P11274 5/20 0.50
KCNH2 Q12809 2/20 0.48
RBP4 P02753 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4783780 0.93 HTR2A (0.59) HTR2AHTR2CABL1BCRKCNH2
SCHEMBL4794769 0.85 HTR2A (0.67) HTR2AHTR2CABL1BCRKCNH2
SCHEMBL4781852 0.85 HTR2A (0.66) HTR2AHTR2CABL1BCRKCNH2
SCHEMBL4781280 0.83 HTR2A (0.66) HTR2AHTR2CKCNH2
SCHEMBL4731508 0.81 HTR2A (0.65) HTR2AHTR2CABL1BCRKCNH2
SCHEMBL4782121 0.81 HTR2A (0.61) HTR2AHTR2CABL1BCRKCNH2
SCHEMBL4783291 0.81 HTR2A (0.61) HTR2AHTR2CABL1BCRKCNH2
SCHEMBL4782575 0.80 HTR2A (0.65) HTR2AHTR2CABL1BCRKCNH2
SCHEMBL4783248 0.80 HTR2A (0.67) HTR2AHTR2CABL1BCRKCNH2
SCHEMBL4784431 0.79 HTR2A (0.66) HTR2AHTR2CABL1BCRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008054748-A2 INDAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2008-05-08 WO claimed
WO-2008054748-A2 INDAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2008-05-08 WO disclosed
WO-2008054748-A2 INDAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2008-05-08 WO disclosed